Literature DB >> 21239360

Monthly unannounced pill counts for monitoring HIV treatment adherence: tests for self-monitoring and reactivity effects.

Seth C Kalichman1, Christina Amaral, Connie Swetsze, Lisa Eaton, Moira O Kalichman, Chauncey Cherry, Mervi Detorio, Angela M Caliendo, Raymond F Schinazi.   

Abstract

BACKGROUND: Unannounced home-based pill counts conducted in person or on the telephone are reliable and valid for monitoring medication adherence. However, expecting to have one's pills counted, organizing medications for pill counts, and increased attention from the person conducting the pill counts may have reactive effects and inadvertently improve adherence. The current study determined whether monthly unannounced pill counts conducted by telephone influence adherence over time.
METHODS: Two prospective cohorts, one drawn from a social support condition in a behavioral intervention trial (n=186) and the other an observational study (n=187), were followed for 12 months and 8 months, respectively. Medication adherence was monitored using monthly unannounced pill counts conducted by telephone. In addition, blood plasma viral load was collected at the final pill count for the observational cohort.
RESULTS: Analyses did not indicate increases in medication adherence over time for antiretroviral or psychiatric medications among men, women, people with detectable and undetectable viral loads, and various medication regimens.
CONCLUSIONS: Unannounced pill counts conducted by telephone do not demonstrate reactivity effects and remain a viable, unobtrusive, objective method of monitoring medication adherence.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21239360      PMCID: PMC7737540          DOI: 10.1310/hct1106-325

Source DB:  PubMed          Journal:  HIV Clin Trials        ISSN: 1528-4336


  12 in total

1.  The natural history of medication compliance in a drug trial: limitations of pill counts.

Authors:  P Rudd; R L Byyny; V Zachary; M E LoVerde; C Titus; W D Mitchell; G Marshall
Journal:  Clin Pharmacol Ther       Date:  1989-08       Impact factor: 6.875

Review 2.  Adherence-resistance relationships to combination HIV antiretroviral therapy.

Authors:  David R Bangsberg; Deanna L Kroetz; Steven G Deeks
Journal:  Curr HIV/AIDS Rep       Date:  2007-05       Impact factor: 5.071

3.  Universal voluntary testing and treatment for prevention of HIV transmission.

Authors:  Carl W Dieffenbach; Anthony S Fauci
Journal:  JAMA       Date:  2009-06-10       Impact factor: 56.272

4.  A simple single-item rating scale to measure medication adherence: further evidence for convergent validity.

Authors:  Seth C Kalichman; Christina M Amaral; Connie Swetzes; Michelle Jones; Rene Macy; Moira O Kalichman; Chauncey Cherry
Journal:  J Int Assoc Physicians AIDS Care (Chic)       Date:  2009 Nov-Dec

5.  Lowering obstacles to HIV prevention services: effects of a brief, telephone-based intervention using motivational enhancement therapy.

Authors:  Joseph F Picciano; Roger A Roffman; Seth C Kalichman; Denise D Walker
Journal:  Ann Behav Med       Date:  2007-10

Review 6.  Preventing HIV antiretroviral resistance through better monitoring of treatment adherence.

Authors:  David R Bangsberg
Journal:  J Infect Dis       Date:  2008-05-15       Impact factor: 5.226

7.  Adherence to antiretroviral therapy assessed by unannounced pill counts conducted by telephone.

Authors:  Seth C Kalichman; Christina M Amaral; Heidi Stearns; Denise White; Jody Flanagan; Howard Pope; Chauncey Cherry; Demetria Cain; Lisa Eaton; Moira O Kalichman
Journal:  J Gen Intern Med       Date:  2007-03-28       Impact factor: 5.128

8.  Monitoring medication adherence by unannounced pill counts conducted by telephone: reliability and criterion-related validity.

Authors:  Seth C Kalichman; Christina M Amaral; Chauncey Cherry; Jody Flanagan; Howard Pope; Lisa Eaton; Moira O Kalichman; Demetria Cain; Mervi Detorio; Angela Caliendo; Raymond F Schinazi
Journal:  HIV Clin Trials       Date:  2008 Sep-Oct

9.  Spending more to save more: interventions to promote adherence.

Authors:  David R Bangsberg; Steven G Deeks
Journal:  Ann Intern Med       Date:  2010-01-05       Impact factor: 25.391

10.  Using electronic drug monitor feedback to improve adherence to antiretroviral therapy among HIV-positive patients in China.

Authors:  Lora L Sabin; Mary Bachman DeSilva; Davidson H Hamer; Keyi Xu; Jianbo Zhang; Tao Li; Ira B Wilson; Christopher J Gill
Journal:  AIDS Behav       Date:  2010-06
View more
  19 in total

1.  Methodological issues in the assessment of diabetes treatment adherence.

Authors:  Jeffrey S Gonzalez; Havah E Schneider
Journal:  Curr Diab Rep       Date:  2011-12       Impact factor: 4.810

2.  Antiretroviral Adherence Following Prison Release in a Randomized Trial of the imPACT Intervention to Maintain Suppression of HIV Viremia.

Authors:  Bethany L DiPrete; Brian W Pence; Carol E Golin; Kevin Knight; Patrick M Flynn; Jessica Carda-Auten; Jennifer S Groves; Kimberly A Powers; Becky L White; Sonia Napravnik; David A Wohl
Journal:  AIDS Behav       Date:  2019-09

3.  Race-based medical mistrust, medication beliefs and HIV treatment adherence: test of a mediation model in people living with HIV/AIDS.

Authors:  Seth C Kalichman; Lisa Eaton; Moira O Kalichman; Tama Grebler; Cynthia Merely; Brandi Welles
Journal:  J Behav Med       Date:  2016-07-09

4.  Drug Use Mediates the Relationship Between Depressive Symptoms and Adherence to ART Among Recently Incarcerated People Living with HIV.

Authors:  Lauren M Hill; Carol E Golin; Nisha C Gottfredson; Brian W Pence; Bethany DiPrete; Jessica Carda-Auten; Jennifer S Groves; Sonia Napravnik; David Wohl; Kevin Knight; Patrick M Flynn
Journal:  AIDS Behav       Date:  2019-08

5.  Unannounced telephone-based pill counts: a valid and feasible method for monitoring adherence.

Authors:  R Fredericksen; B J Feldman; T Brown; S Schmidt; P K Crane; R D Harrington; S Dhanireddy; J McReynolds; W B Lober; D R Bangsberg; M M Kitahata; Heidi M Crane
Journal:  AIDS Behav       Date:  2014-12

6.  Phone-delivered mindfulness training to promote medication adherence and reduce sexual risk behavior among persons living with HIV: Design and methods.

Authors:  Elena Salmoirago-Blotcher; Carla Rich; Rochelle K Rosen; Shira Dunsiger; Aadia Rana; Michael P Carey
Journal:  Contemp Clin Trials       Date:  2016-12-23       Impact factor: 2.226

7.  HIV-Related Stress and Life Chaos Mediate the Association Between Poverty and Medication Adherence Among People Living with HIV/AIDS.

Authors:  Seth C Kalichman; Moira O Kalichman
Journal:  J Clin Psychol Med Settings       Date:  2016-12

8.  Real-time medication adherence monitoring intervention: test of concept in people living with HIV infection.

Authors:  Jennifer A Pellowski; Seth C Kalichman; Denise White; Christina M Amaral; Ginger Hoyt; Moira O Kalichman
Journal:  J Assoc Nurses AIDS Care       Date:  2014-07-16       Impact factor: 1.354

9.  Adherence and viral suppression among infants and young children initiating protease inhibitor-based antiretroviral therapy.

Authors:  Chloe A Teasdale; Elaine J Abrams; Ashraf Coovadia; Renate Strehlau; Leigh Martens; Louise Kuhn
Journal:  Pediatr Infect Dis J       Date:  2013-05       Impact factor: 2.129

10.  Correlation between pill counts and biologic effects in an HIV-1 prevention clinical trial: implications for measuring adherence.

Authors:  Deborah J Donnell; Jared M Baeten; Ting Hong; Jairam R Lingappa; Andrew Mujugira; Edith Nakku-Joloba; David Bangsberg; Connie Celum
Journal:  AIDS Behav       Date:  2013-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.